Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin’s lymphoma: a consortium for improving survival of lymphoma (CISL) trial

Overview of attention for article published in Investigational New Drugs, September 2009

Altmetric Badge

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 18 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Non-Hodgkin’s lymphoma: diagnosis and management : Appendix G: Evidence review

Cited by National Institute for Health and Care Excellence on 18 Jul 2016

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.